Predictive Oncology Price to Free Cash Flow Ratio 2010-2024 | POAI

Historical price to free cash flow ratio values for Predictive Oncology (POAI) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Predictive Oncology Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2024-11-12 0.79 0.00
2024-06-30 1.04 $-2.96 0.00
2024-03-31 2.55 $-3.33 0.00
2023-12-31 3.29 $-3.35 0.00
2023-09-30 3.20 $-3.62 0.00
2023-06-30 4.86 $-3.44 0.00
2023-03-31 6.54 $-3.39 0.00
2022-12-31 6.13 $-3.47 0.00
2022-09-30 7.20 $-4.40 0.00
2022-06-30 8.20 $-4.26 0.00
2022-03-31 19.54 $-3.70 0.00
2021-12-31 19.04 $-4.78 0.00
2021-09-30 26.60 $-10.28 0.00
2021-06-30 26.20 $-9.68 0.00
2021-03-31 24.20 $-10.51 0.00
2020-12-31 14.65 $-20.69 0.00
2020-09-30 16.28 $-36.38 0.00
2020-06-30 32.80 $-60.82 0.00
2020-03-31 31.51 $-47.07 0.00
2019-12-31 52.20 $-60.89 0.00
2019-09-30 101.00 $-59.05 0.00
2019-06-30 149.50 $-44.25 0.00
2019-03-31 150.00 $-81.00 0.00
2018-12-31 123.82 $-85.29 0.00
2018-09-30 212.00 $-103.52 0.00
2018-06-30 226.00 $-127.70 0.00
2018-03-31 220.00 $-135.26 0.00
2017-12-31 202.00 $-141.60 0.00
2017-09-30 290.72 $-190.13 0.00
2017-06-30 294.00 $-173.11 0.00
2017-03-31 420.00 $94.03 4.47
2016-12-31 560.00 $-312.73 0.00
2016-09-30 825.00 $-243.74 0.00
2016-06-30 762.50 $-256.59 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.005B $0.002B
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $10.500B 0.00
Hims & Hers Health (HIMS) United States $5.733B 148.28
Inspire Medical Systems (INSP) United States $5.716B 178.27
Axonics (AXNX) United States $3.603B 1762.25
IRhythm Technologies (IRTC) United States $2.729B 0.00
Privia Health (PRVA) United States $2.710B 225.80
Enovis (ENOV) United States $2.621B 17.77
Omnicell (OMCL) United States $2.264B 74.08
Azenta (AZTA) United States $2.250B 112.17
10x Genomics (TXG) United States $1.898B 0.00
Schrodinger (SDGR) United States $1.620B 0.00
Clover Health Investments (CLOV) United States $1.617B 0.00
Phreesia (PHR) United States $1.235B 0.00
Standard BioTools (LAB) United States $0.763B 0.00
Fulgent Genetics (FLGT) United States $0.586B 0.00
Butterfly Network (BFLY) United States $0.571B 0.00
Talkspace (TALK) United States $0.569B 0.00
Definitive Healthcare (DH) United States $0.528B 91.40
Health Catalyst (HCAT) United States $0.495B 0.00
Pulmonx (LUNG) United States $0.278B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.261B 0.00
TruBridge (TBRG) United States $0.234B 67.96
P3 Health Partners (PIII) United States $0.140B 0.00
American Well (AMWL) United States $0.136B 0.00
EUDA Health Holdings (EUDA) Singapore $0.098B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.063B 0.00
111 (YI) China $0.056B 0.00
CareCloud (CCLD) United States $0.051B 0.00
Zepp Health (ZEPP) China $0.049B 0.00
Outset Medical (OM) United States $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.041B 0.00
Movano (MOVE) United States $0.028B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
MSP Recovery (LIFW) United States $0.017B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00